EUVIMEDEUVIMED entdecken
Multizentrische Studie

AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population

Nobuyuki Hinata iD, Masato Fujisawa, Raizo Yamaguchi, Daiki Katsura, Hiroyuki Kitano, Yohei Sekino, Kunihiko Yoshioka, Shin Koike, Yu Odagaki, Yu Ozawa iD, Keisuke Aoki, Toshihide Miyauchi und 7 weitere

International Journal of Urology · 2025

DOI: 10.1111/iju.15651 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Nobuyuki Hinata und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Hiroshima Prefecture, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Robotic Surgical Procedures, Ablation Techniques. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the safety, efficacy, and patient‐reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population.

Methods

This post‐market use‐results survey included 103 Japanese men with BPH who underwent Aquablation across five centers with previously Aquablation naïve physicians. Data were collected at baseline, during the procedure, at discharge, and at 3 and 6 months post‐procedure. Key outcomes included International Prostate Symptom Score (IPSS), quality of life (QoL), uroflowmetry parameters, and adverse events.

Results

The mean age of patients was 71.1 years, and the average prostate size was 82.3 mL. At 6 months, the mean IPSS significantly improved from 18.1 ± 9.0 to 6.1 ± 5.0 ( p < 0.0001), and QoL scores improved from 4.9 ± 1.3 to 1.8 ± 1.3 ( p < 0.0001). Uroflowmetry showed a significant increase in Qmax from 8.3 ± 4.4 to 15.5 ± 7.8 mL/s ( p < 0.0001) and a decrease in post‐void residual volume (PVR) from 85.6 ± 107.2 to 43.3 ± 60.0 mL ( p = 0.0006). At the 30‐day primary safety endpoint, there were no reported adverse events of pad‐use incontinence, erectile dysfunction, or ejaculatory dysfunction reported, and no device‐related serious adverse events were reported. One subject (0.97%) experienced a Clavien–Dindo grade 3 adverse event.

Conclusions

Aquablation therapy using the AQUABEAM Robotic System is a reproducible, safe, and effective treatment for Japanese men with BPH, providing significant improvements in LUTS and QoL with a favorable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaLower Urinary Tract SymptomsRobotic Surgical ProceduresAblation TechniquesHumansMaleAgedQuality of LifeJapanMiddle AgedTreatment OutcomeAged, 80 and overPatient Reported Outcome MeasuresAquablationEast Asian People

Stichwörter der Autor:innen

AQUABEAMAquablationJapanesebenign prostatic hyperplasialower urinary tract symptoms

Autor:innen und Institutionen

  • Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Hiroshima Prefecture, Japan.
  • Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyōgo Prefecture, Japan.
  • Department of Urology, Itabashi Chuo Medical Center, Itabashi, Tokyo, Japan.
  • Oita Urology Hospital, Bunyo, Oita, Japan.
  • Frimley Health NHS Foundation Trust, Frimley, UK.
  • Division of Urology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Nobuyuki Hinata, Yu Ozawa, Dean Elterman

Zitieren

APA

Hinata, N., Fujisawa, M., Yamaguchi, R., Katsura, D., Kitano, H., Sekino, Y., Yoshioka, K., Koike, S., Odagaki, Y., Ozawa, Y., Aoki, K., Miyauchi, T., Watanabe, S., Barber, N., Elterman, D., Afshar, A., Saito, K., Ide, H., & Horie, S. (2025). AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population. International Journal of Urology. https://doi.org/10.1111/iju.15651

Vancouver

Hinata N, Fujisawa M, Yamaguchi R, Katsura D, Kitano H, Sekino Y, et al. AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population. International Journal of Urology. 2025. doi:10.1111/iju.15651

BibTeX
@article{Hinata2025,
  author = {Hinata, Nobuyuki and Fujisawa, Masato and Yamaguchi, Raizo and Katsura, Daiki and Kitano, Hiroyuki and Sekino, Yohei and Yoshioka, Kunihiko and Koike, Shin and Odagaki, Yu and Ozawa, Yu and Aoki, Keisuke and Miyauchi, Toshihide and Watanabe, Susumu and Barber, Neil and Elterman, Dean and Afshar, Ali and Saito, Keisuke and Ide, Hisamitsu and Horie, Shigeo},
  title = {AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.15651}
}
Kostenlos starten →